Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0084
0.00 (0.00%)
Jun 1, 2026, 4:00 PM EST

YBGJ Statistics

Total Valuation

YBGJ has a market cap or net worth of 1.43 million. The enterprise value is 2.94 million.

Market Cap1.43M
Enterprise Value 2.94M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026.

Earnings Date Aug 11, 2026
Ex-Dividend Date n/a

Share Statistics

YBGJ has 170.42 million shares outstanding. The number of shares has increased by 3.76% in one year.

Current Share Class 170.42M
Shares Outstanding 170.42M
Shares Change (YoY) +3.76%
Shares Change (QoQ) -0.20%
Owned by Insiders (%) 67.41%
Owned by Institutions (%) n/a
Float 14.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 115.89
PB Ratio -0.62
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.21
EV / Sales 238.25
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -4.52

Financial Position

The company has a current ratio of 0.20

Current Ratio 0.20
Quick Ratio 0.14
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -2.25
Interest Coverage -168.95

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -67.26%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 43.72%
Weighted Average Cost of Capital (WACC) 3.97%
Revenue Per Employee 882
Profits Per Employee -65,445
Employee Count14
Asset Turnover 0.01
Inventory Turnover 0.14

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -86.00% in the last 52 weeks. The beta is 0.63, so YBGJ's price volatility has been lower than the market average.

Beta (5Y) 0.63
52-Week Price Change -86.00%
50-Day Moving Average 0.03
200-Day Moving Average 0.10
Relative Strength Index (RSI) 37.04
Average Volume (20 Days) 29,014

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, YBGJ had revenue of 12,353 and -916,226 in losses. Loss per share was -0.01.

Revenue12,353
Gross Profit 8,165
Operating Income -1.01M
Pretax Income -1.02M
Net Income -916,226
EBITDA -847,450
EBIT -1.01M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 10,382 in cash and 1.47 million in debt, with a net cash position of -1.46 million or -0.01 per share.

Cash & Cash Equivalents 10,382
Total Debt 1.47M
Net Cash -1.46M
Net Cash Per Share -0.01
Equity (Book Value) -2.31M
Book Value Per Share -0.01
Working Capital -2.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -657,916 and capital expenditures 6,186, giving a free cash flow of -651,730.

Operating Cash Flow -657,916
Capital Expenditures 6,186
Depreciation & Amortization 162,221
Net Borrowing 786,288
Free Cash Flow -651,730
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross Margin 66.10%
Operating Margin -8,173.49%
Pretax Margin -8,221.87%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

YBGJ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.76%
Shareholder Yield -3.76%
Earnings Yield -64.00%
FCF Yield -45.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2